Table 3

Patients With Prior Bypass Surgery (Without Acute Coronary Syndrome)

IndicationAppropriate Use Score (1–9)
CCS Angina ClassAsymptomaticI or IIIII or IV
50.
  • One or more stenoses in saphenous vein graft(s)

  • Low-risk findings on noninvasive testing including normal LV systolic function

  • Receiving no or minimal anti-ischemic medical therapy

I (3)U (4)U (6)
51.
  • One or more stenoses in saphenous vein graft(s)

  • Low-risk findings on noninvasive testing including normal LV systolic function

  • Receiving a course of maximal anti-ischemic medical therapy

U (4)U (6)A (7)
52.
  • One or more stenoses in saphenous vein graft(s)

  • Intermediate-risk findings on noninvasive testing

  • Receiving no or minimal anti-ischemic medical therapy

U (4)U (6)A (7)
53.
  • One or more stenoses in saphenous vein graft(s)

  • Intermediate-risk findings on noninvasive testing

  • Receiving a course of maximal anti-ischemic medical therapy

U (4)A (7)A (8)
54.
  • One or more stenoses in saphenous vein graft(s)

  • High-risk findings on noninvasive testing

  • Receiving no or minimal anti-ischemic medical therapy

U (6)A (7)A (7)
55.
  • One or more stenoses in saphenous vein graft(s)

  • High-risk findings on noninvasive testing

  • Receiving a course of maximal anti-ischemic medical therapy

A (7)A (8)A (9)
56.
  • One or more lesions in native coronary arteries without bypass grafts

  • All bypass grafts patent and without significant disease

  • Low-risk findings on noninvasive testing including normal LV systolic function

  • Receiving no or minimal anti-ischemic medical therapy

Not ratedI (3)U (6)
57.
  • One or more lesions in native coronary arteries without bypass grafts

  • All bypass grafts patent and without significant disease

  • Low-risk findings on noninvasive testing including normal LV systolic function

  • Receiving a course of maximal anti-ischemic medical therapy

I (3)U (5)A (7)
58.
  • One or more lesions in native coronary arteries without bypass grafts

  • All bypass grafts patent and without significant disease

  • Intermediate-risk findings on noninvasive testing

  • Receiving no or minimal anti-ischemic medical therapy

I (3)U (5)A (7)
59.
  • One or more lesions in native coronary arteries without bypass grafts

  • All bypass grafts patent and without significant disease

  • Intermediate-risk findings on noninvasive testing

  • Receiving a course of maximal anti-ischemic medical therapy

U (4)U (6)A (8)
60.
  • One or more lesions in native coronary arteries without bypass grafts

  • All bypass grafts patent and without significant disease

  • High-risk findings on noninvasive testing

  • Receiving no or minimal anti-ischemic medical therapy

U (6)A (7)A (8)
61.
  • One or more lesions in native coronary arteries without bypass grafts

  • All bypass grafts patent and without significant disease

  • High-risk findings on noninvasive testing

  • Receiving a course of maximal anti-ischemic medical therapy

U (5)A (8)A (9)

A = appropriate; CCS = Canadian Cardiovascular Society; I = inappropriate; LV = left ventricular; U = uncertain.